BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 112 filers reported holding BIOSCRIP INC in Q2 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $7,000 | +75.0% | 4,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $4,000 | -66.7% | 4,000 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $12,000 | +20.0% | 4,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $10,000 | +11.1% | 4,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $9,000 | +28.6% | 4,000 | 0.0% | 0.00% | +100.0% |
Q4 2015 | $7,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
First Washington CORP | 454,200 | $3,788,000 | 2.12% |
GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |